
3 Engines and Power Generators Maker, Drug Ingredients Maker and Auto Cables Maker Stocks With a Strong Future Roadmap: Cummins India, Neuland Laboratories and Suprajit Engineering
Cummins India, Neuland Laboratories and Suprajit Engineering: ROE of 12.7% to 27.9% and FY22 to FY26 revenue CAGR of 18.5% to 21.1%. Prices as of 17 Nov 2026.
Updated: 18 Nov 2026 • 3:40 pm
Posted by:

Quick Answer
The three engine, drug ingredient and auto cable stocks to watch are Cummins India, Neuland Laboratories and Suprajit Engineering. Their return on equity ranges from 12.7% to 27.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 18.5% to 21.1%. Cummins India has the highest return on equity at 27.9%, while Neuland Laboratories has the fastest revenue growth at 21.1% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.
Engine, drug ingredient and auto cable stocks offer a focused view of a sector where demand keeps widening. Cummins India, Neuland Laboratories and Suprajit Engineering cover an engines and power generators maker, a drug ingredients maker and an auto cables maker.
This list covers three engine, drug ingredient and auto cable stocks with complete current figures: Cummins India, Neuland Laboratories and Suprajit Engineering. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Engine, Drug Ingredient and Auto Cable Stocks?
Engine, drug ingredient and auto cable stocks are listed companies that make engines and power generators for industry and data centres, make active drug ingredients for global pharma firms, and make control cables and wiring parts for vehicles. Their earnings depend on backup power demand, drug orders and vehicle output.
Engine, Drug Ingredient and Auto Cable Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Cummins India | 4,065 | 127,515 | 53.9 | 44.4 | 27.9 | 0.00 |
| Neuland Laboratories | 21,445 | 24,665 | 49.5 | 36.0 | 19.4 | 0.16 |
| Suprajit Engineering | 445.15 | 6,286 | 33.6 | 36.1 | 12.7 | 0.69 |
On valuation, Suprajit Engineering trades at a P/E below the industry P/E, while Cummins India and Neuland Laboratories trade above it, which reflects the growth the market already expects. Readers comparing engine, drug ingredient and auto cable stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Engine, Drug Ingredient and Auto Cable Stocks Have a Strong Roadmap in India?
Engine, drug ingredient and auto cable stocks have a strong roadmap in India because strong demand for backup power, rising outsourcing of drug making and steady vehicle output keep widening the market for these companies.
- Engines and generators. Data centres and factories need backup power.
- Drug ingredients. Pharma firms source from reliable plants.
- Auto cables. Every vehicle needs control cables.
Why Cummins India Features Among These Engine, Drug Ingredient and Auto Cable Stocks
Among the engine, drug ingredient and auto cable stocks on this list, Cummins India makes diesel and natural gas engines, generator sets, filtration products and power systems for infrastructure, data centres and industrial customers, and it also exports.
Revenue rose from Rs 6,414 crore in FY22 to Rs 12,661 crore in FY26, a compound annual growth rate of 18.5%. Net profit grew from Rs 934 crore in FY22 to Rs 2,362 crore in FY26, which works out to a compound annual growth rate of 26.1%.
In the June 2026 quarter, revenue grew 17.2% year on year to Rs 3,563 crore, while net profit rose 0.9% to Rs 609 crore. The company has a return on equity of 27.9%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 127,515 crore. The stock trades at a P/E of 53.9, above the industry P/E of 44.4.
Roadmap: The company benefits from demand for backup power at data centres, infrastructure projects and industrial plants, and it is widening its export base. A debt-free balance sheet supports capacity additions and new product lines.
What to watch: Track demand from data centres and new infrastructure and the growth of exports.
Why Neuland Laboratories Features Among These Engine, Drug Ingredient and Auto Cable Stocks
Among the power generator, API maker and control cable shares on this list, Neuland Laboratories, based in Hyderabad, makes active pharmaceutical ingredients for generic drugs and runs a custom manufacturing business that supplies innovator companies.
Revenue rose from Rs 953 crore in FY22 to Rs 2,053 crore in FY26, a compound annual growth rate of 21.1%. Net profit grew from Rs 63.8 crore in FY22 to Rs 364 crore in FY26, which works out to a compound annual growth rate of 54.5%.
The company has a return on equity of 19.4%, a debt to equity ratio of 0.16 and a market capitalisation of Rs 24,665 crore. The stock trades at a P/E of 49.5, above the industry P/E of 36.0.
Roadmap: The company is moving up the value chain by growing custom manufacturing, which carries longer contracts and better margins than commodity generic ingredients. A strong order book for development-stage molecules gives visibility on multi-year volumes.
What to watch: Custom manufacturing revenue can move between quarters, so review the full-year trend.
Why Suprajit Engineering Features Among These Engine, Drug Ingredient and Auto Cable Stocks
Among the three companies on this list, Suprajit Engineering is a Bengaluru-based maker of automotive cables and control systems, lighting products and other components for two-wheelers, cars and commercial vehicles, with a presence in many countries.
The company has a return on equity of 12.7%, a debt to equity ratio of 0.69 and a market capitalisation of Rs 6,286 crore. The stock trades at a P/E of 33.6, below the industry P/E of 36.1.
Revenue rose from Rs 1,877 crore in FY22 to Rs 3,941 crore in FY26, a compound annual growth rate of 20.4%. Net profit grew from Rs 152 crore in FY23 to Rs 183 crore in FY26, which works out to a compound annual growth rate of 6.3%. In the June 2026 quarter, revenue grew 19.1% year on year to Rs 1,074 crore, while net profit rose 8.6% to Rs 52.2 crore.
Roadmap: The company is widening its mix through lighting, electronics and aftermarket products while keeping its strong cable franchise. A global footprint supports orders from international vehicle makers.
What to watch: Follow growth in new product lines, export programmes and margin trends.
Cummins India vs Neuland Laboratories vs Suprajit Engineering on Key Financials
The table below sets the three engine, drug ingredient and auto cable stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Cummins India | 6,414 | 12,661 | 18.5% | 2,362 | 18.7% |
| Neuland Laboratories | 953 | 2,053 | 21.1% | 364 | 17.7% |
| Suprajit Engineering | 1,877 | 3,941 | 20.4% | 183 | 4.6% |
Cummins India posts the highest return on equity in this group at 27.9%. Cummins India has the largest FY26 revenue at Rs 12,661 crore, and Neuland Laboratories shows the fastest revenue growth with a 21.1% compound annual rate. A useful habit with engine, drug ingredient and auto cable stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Engine, Drug Ingredient and Auto Cable Stocks
Every theme carries risks that deserve a check before any decision. For these engine, drug ingredient and auto cable stocks, the main points are: Long-term power generator, API maker and control cable shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Order timing. Project awards can shift between periods.
- Regulatory approvals. Plant inspections and approvals can affect supplies.
- Demand cycles. Sales can vary with seasons and rates.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter engine, drug ingredient and auto cable stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Engine, Drug Ingredient and Auto Cable Stocks
Engine, drug ingredient and auto cable stocks reward patient research into demand, execution and financial strength. Cummins India, Neuland Laboratories and Suprajit Engineering each have a clear plan to grow. Based on the 17 November 2026 close, Cummins India trades at Rs 4,065, Neuland Laboratories at Rs 21,445 and Suprajit Engineering at Rs 445.15. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these engine, drug ingredient and auto cable stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track engine, drug ingredient and auto cable stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are engine, drug ingredient and auto cable stocks?
Ans. Engine, drug ingredient and auto cable stocks are listed companies that make engines and power generators for industry and data centres, make active drug ingredients for global pharma firms, and make control cables and wiring parts for vehicles. Their earnings depend on backup power demand, drug orders and vehicle output. This list looks at three of them, Cummins India, Neuland Laboratories and Suprajit Engineering, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.
Which engine, drug ingredient and auto cable stocks are covered in this list?
Ans. This list covers Cummins India, Neuland Laboratories and Suprajit Engineering. Based on the 17 November 2026 close, Cummins India traded at Rs 4,065, Neuland Laboratories at Rs 21,445 and Suprajit Engineering at Rs 445.15. Their return on equity ranges from 12.7% to 27.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 18.5% to 21.1%.
Why do engine, drug ingredient and auto cable stocks have a strong future roadmap in India?
Ans. Engine, drug ingredient and auto cable stocks have a strong roadmap in India because strong demand for backup power, rising outsourcing of drug making and steady vehicle output keep widening the market for these companies. The main drivers are as follows. Engines and generators. Data centres and factories need backup power. Drug ingredients. Pharma firms source from reliable plants. Auto cables. Every vehicle needs control cables. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Cummins India performed financially?
Ans. Revenue rose from Rs 6,414 crore in FY22 to Rs 12,661 crore in FY26, a compound annual growth rate of 18.5%. Net profit grew from Rs 934 crore in FY22 to Rs 2,362 crore in FY26, which works out to a compound annual growth rate of 26.1%. In the June 2026 quarter, revenue grew 17.2% year on year to Rs 3,563 crore, while net profit rose 0.9% to Rs 609 crore. The company has a return on equity of 27.9%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 127,515 crore. The stock trades at a P/E of 53.9, above the industry P/E of 44.4. Looking ahead, the company benefits from demand for backup power at data centres, infrastructure projects and industrial plants, and it is widening its export base. A debt-free balance sheet supports capacity additions and new product lines.
How has Neuland Laboratories performed financially?
Ans. Revenue rose from Rs 953 crore in FY22 to Rs 2,053 crore in FY26, a compound annual growth rate of 21.1%. Net profit grew from Rs 63.8 crore in FY22 to Rs 364 crore in FY26, which works out to a compound annual growth rate of 54.5%. The company has a return on equity of 19.4%, a debt to equity ratio of 0.16 and a market capitalisation of Rs 24,665 crore. The stock trades at a P/E of 49.5, above the industry P/E of 36.0. Looking ahead, the company is moving up the value chain by growing custom manufacturing, which carries longer contracts and better margins than commodity generic ingredients. A strong order book for development-stage molecules gives visibility on multi-year volumes.
How has Suprajit Engineering performed financially?
Ans. Revenue rose from Rs 1,877 crore in FY22 to Rs 3,941 crore in FY26, a compound annual growth rate of 20.4%. Net profit grew from Rs 152 crore in FY23 to Rs 183 crore in FY26, which works out to a compound annual growth rate of 6.3%. In the June 2026 quarter, revenue grew 19.1% year on year to Rs 1,074 crore, while net profit rose 8.6% to Rs 52.2 crore. The company has a return on equity of 12.7%, a debt to equity ratio of 0.69 and a market capitalisation of Rs 6,286 crore. The stock trades at a P/E of 33.6, below the industry P/E of 36.1. Looking ahead, the company is widening its mix through lighting, electronics and aftermarket products while keeping its strong cable franchise. A global footprint supports orders from international vehicle makers.
What risks should investors check before buying engine, drug ingredient and auto cable stocks?
Ans. Investors should check a few risks before buying engine, drug ingredient and auto cable stocks. Order timing. Project awards can shift between periods. Regulatory approvals. Plant inspections and approvals can affect supplies. Demand cycles. Sales can vary with seasons and rates. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of engine, drug ingredient and auto cable stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

3 Ceramic Tiles Maker, Precision Components Maker and Abrasives Maker Stocks With a Strong Future Roadmap: Kajaria Ceramics, Craftsman Automation and Grindwell Norton
18 November 2026

3 Steel Tubes Maker, Hospitals Chain and Pistons and Engine Parts Maker Stocks With a Strong Future Roadmap: APL Apollo Tubes, Krishna Institute of Medical Sciences and SPR Auto Technologies
18 November 2026

3 Corn Starch Processor, Formulations Maker and Gold Jewellery Chain Stocks With a Strong Future Roadmap: Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India
18 November 2026

3 Drug Ingredients Maker, Port Operator and Auto Lighting Maker Stocks With a Strong Future Roadmap: Granules India, Gujarat Pipavav Port and Varroc Engineering
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
3 Ceramic Tiles Maker, Precision Components Maker and Abrasives Maker Stocks With a Strong Future Roadmap: Kajaria Ceramics, Craftsman Automation and Grindwell Norton
3 Steel Tubes Maker, Hospitals Chain and Pistons and Engine Parts Maker Stocks With a Strong Future Roadmap: APL Apollo Tubes, Krishna Institute of Medical Sciences and SPR Auto Technologies
3 Corn Starch Processor, Formulations Maker and Gold Jewellery Chain Stocks With a Strong Future Roadmap: Gujarat Ambuja Exports, Strides Pharma Science and Kalyan Jewellers India
3 Drug Ingredients Maker, Port Operator and Auto Lighting Maker Stocks With a Strong Future Roadmap: Granules India, Gujarat Pipavav Port and Varroc Engineering
3 Ice Cream Maker, Laminated Tubes Maker and Engineering Consultancy Stocks With a Strong Future Roadmap: Vadilal Industries, EPL and Engineers India

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





